Metraipolis › archive › dc_105fee602f85

Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a… — Europe PMC PMID:41175237

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41175237
DOI
10.1007/s00432-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-08T20:50:12.298Z
SHA-256 of the archived text
185c406b80516f2605864d8091e69cc4576d8ce2095b55e9df9098b73b5bdf41
Stable URL of this page
https://metraipolis.com/documento/dc_105fee602f85

How to cite

Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a… — Europe PMC PMID:41175237 — Europe PMC (en), https://europepmc.org/article/MED/41175237 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_105fee602f85 (Metraipolis archive dc_105fee602f85, sha256 185c406b80516f2605864d8091e69cc4576d8ce2095b55e9df9098b73b5bdf41)
BibTeX
@misc{dc105fee602f85,
  title = {Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a… — Europe PMC PMID:41175237},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41175237},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_105fee602f85; sha256 185c406b80516f2605864d8091e69cc4576d8ce2095b55e9df9098b73b5bdf41},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41175237. Agents can read the archived copy with the MCP tool read_document.